Previous close | 53.09 |
Open | 53.70 |
Bid | 53.73 x 300 |
Ask | 53.77 x 300 |
Day's range | 52.73 - 53.87 |
52-week range | 50.27 - 67.36 |
Volume | |
Avg. volume | 1,889,353 |
Market cap | 12.071B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 16.29 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Q1 2024 Insight Enterprises Inc Earnings Call
Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript April 30, 2024 Incyte Corporation misses on earnings expectations. Reported EPS is $0.746 EPS, expectations were $0.88. INCY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to Incyte First […]
Incyte's (INCY) first-quarter 2024 earnings and revenues miss estimates. The company maintains 2024 revenue guidance for its lead drug, Jakafi.